Sinopharm Group Co (HKSE:01099) EV-to-EBIT : 6.03 (As of Apr. 29, 2024)

Sinopharm Group Co EV-to-EBIT Chart

Sinopharm Group Co Annual Data
	Trend	Dec14	Dec15	Dec16	Dec17	Dec18	Dec19	Dec20	Dec21	Dec22	Dec23
EV-to-EBIT		Get a 7-Day Free Trial					7.06	5.33	5.10	5.06	5.08

Sinopharm Group Co Quarterly Data
	Jun15	Dec15	Jun16	Dec16	Jun17	Dec17	Jun18	Dec18	Jun19	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Sep22	Dec22	Jun23	Sep23	Dec23
EV-to-EBIT	Get a 7-Day Free Trial															8.72	5.06	13.86	5.47	-

Competitive Comparison of Sinopharm Group Co's EV-to-EBIT

For the Medical Distribution subindustry, Sinopharm Group Co's EV-to-EBIT, along with its competitors' market caps and EV-to-EBIT data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Sinopharm Group Co's EV-to-EBIT Distribution in the Medical Distribution Industry

For the Medical Distribution industry and Healthcare sector, Sinopharm Group Co's EV-to-EBIT distribution charts can be found below:

* The bar in red indicates where Sinopharm Group Co's EV-to-EBIT falls into.

Sinopharm Group Co EV-to-EBIT Calculation

Sinopharm Group Co's EV-to-EBIT for today is calculated as:

Sinopharm Group Co's current Enterprise Value is HK$78,027 Mil.
Sinopharm Group Co's EBIT for the trailing twelve months (TTM) ended in Sep. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was HK$12,943 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Sinopharm Group Co  (HKSE:01099) EV-to-EBIT Explanation

This is a more accurate valuation of companies' operation because it considers the debt and cash on its balance sheet, and non-operating items such as interest payment, tax, and one-time items are not included in the Operating Income.

Joel Greenblatt calls the inversion of this ratio Earnings Yield (Joel Greenblatt) %.

Sinopharm Group Co's Earnings Yield (Joel Greenblatt) % for the quarter that ended in Sep. 2023 is calculated as:

Sinopharm Group Co's Enterprise Value for the quarter that ended in Sep. 2023 was HK$70,839 Mil.
Sinopharm Group Co's EBIT for the trailing twelve months (TTM) ended in Sep. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was HK$12,943 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Sinopharm Group Co EV-to-EBIT Related Terms

Thank you for viewing the detailed overview of Sinopharm Group Co's EV-to-EBIT provided by GuruFocus.com. Please click on the following links to see related term pages.

Sinopharm Group Co (HKSE:01099) Business Description